Variability in lung cancer response to ALK inhibitors cannot be explained by the diversity of ALK fusion variants-Reference-Cited by-同舟云学术

Variability in lung cancer response to ALK inhibitors cannot be explained by the diversity of ALK fusion variants

Published:2018-11 Issue: Volume:154 Page:19-24
ISSN:0300-9084
Container-title:Biochimie
language:en
Short-container-title:Biochimie

Author:

Mitiushkina Natalia V.,Tiurin Vladislav I.,Iyevleva Aglaya G.,Kholmatov Maxim M.,Filippova Elena A.,Moiseyenko Fedor V.,Levchenko Nikita E.,Sardaryan Ivan S.,Odintsova Svetlana V.,Lozhkina Alexandra M.^ORCID,Volkov Nikita M.,Karaseva Nina A.,Moiseyenko Vladimir M.,Orlov Sergey V.,Imyanitov Evgeny N.

Funder

Russian Scientific

Publisher

Elsevier BV

Subject

General Medicine,Biochemistry

Reference31 articles.

1. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

2. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer;Rikova;Cell,2007

3. Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma;Christensen;Mol. Canc. Therapeut.,2007

4. An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms;Zou;Canc. Res.,2007

5. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer;Kwak;N. Engl. J. Med.,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SDK1-ALK Fusion in a Lung Adenocarcinoma Patient With Excellent Response to ALK Inhibitor Treatment: A Case Report;Frontiers in Oncology;2022-03-04

2. The impact of the ALK fusion variant on clinical outcomes in EML4-ALK patients with NSCLC: a systematic review and meta-analysis;Future Oncology;2022-01

3. Sensitivity of eight types of ALK fusion variant to alectinib in ALK-transformed cells;Anti-Cancer Drugs;2021-09-13

4. Targeting EML4-ALK gene fusion variant 3 in thyroid cancer;Endocrine-Related Cancer;2021-06-01

5. Are all ALK variants created equal? Clinicopathologic features and outcomes: a propensity-matched study;International Journal of Clinical Oncology;2021-04-12